ELV 📈 Elevance Health - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0367521038

ELV: Health Insurance, Pharmacy Services, Managed Care, Wellness Programs

Elevance Health Inc, a leading health benefits company in the United States, operates through four key segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. These segments work together to provide a comprehensive range of health plans, services, and products to its program members.

The company's Health Benefits segment offers a diverse portfolio of health insurance products, including stop loss, dental, vision, life, disability, and supplemental health insurance benefits. Additionally, it provides fee-based administrative managed care services, enabling clients to outsource specific healthcare management functions.

The CarelonRx segment focuses on pharmacy services, including pharmacy benefit management, home delivery, and specialty pharmacies. This segment also offers claims adjudication, formulary management, pharmacy networks, rebate administration, and a prescription drug database, making it a one-stop-shop for pharmacy-related needs.

The Carelon Services segment provides a wide range of healthcare-related services and capabilities, such as utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs. This segment also offers services related to data management, information technology, and business operations, making it a valuable partner for healthcare organizations.

In addition to these segments, Elevance Health Inc is involved in the National Government Services business, which provides healthcare services to government-sponsored programs. The company operates under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names, offering a trusted and recognizable presence in the healthcare industry.

With a rich history dating back to 2001, Elevance Health Inc, formerly known as Anthem, Inc., rebranded in June 2022 to reflect its evolving focus on whole-person health and well-being. Headquartered in Indianapolis, Indiana, the company continues to drive innovation and excellence in the healthcare industry.

Additional Sources for ELV Stock

ELV Stock Overview

Market Cap in USD 93,604m
Sector Healthcare
Industry Healthcare Plans
GiC Industry Health Care Providers & Services
TER 0.00%
IPO / Inception 2001-01-02

ELV Stock Ratings

Growth 5y 50.2%
Fundamental 43.4%
Dividend 59.7%
Rel. Performance Sector -2.78
Analysts 4.45/5
Fair Price Momentum 363.14 USD
Fair Price DCF 97.16 USD

ELV Dividends

Dividend Yield 12m 1.60%
Yield on Cost 5y 2.42%
Annual Growth 5y 13.09%
Payout Consistency 100.00%

ELV Growth Ratios

Growth Correlation 3m -94.7%
Growth Correlation 12m 10.8%
Growth Correlation 5y 84.5%
CAGR 5y 8.67%
CAGR/Mean DD 5y 1.02
Sharpe Ratio 12m -0.78
Alpha -49.32
Beta 1.02
Volatility 22.51%
Current Volume 1692.1k
Average Volume 20d 1883.6k
What is the price of ELV stocks?
As of December 04, 2024, the stock is trading at USD 408.07 with a total of 1,692,129 shares traded.
Over the past week, the price has changed by +1.52%, over one month by -2.34%, over three months by -27.21% and over the past year by -14.48%.
Is Elevance Health a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Elevance Health (NYSE:ELV) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 43.42 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ELV as of December 2024 is 363.14. This means that ELV is currently overvalued and has a potential downside of -11.01%.
Is ELV a buy, sell or hold?
Elevance Health has received a consensus analysts rating of 4.45. Therefor, it is recommend to buy ELV.
  • Strong Buy: 13
  • Buy: 6
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0
What are the forecast for ELV stock price target?
According to ValueRays Forecast Model, ELV Elevance Health will be worth about 398.3 in December 2025. The stock is currently trading at 408.07. This means that the stock has a potential downside of -2.4%.
Issuer Forecast Upside
Wallstreet Target Price 520.1 27.5%
Analysts Target Price 570 39.7%
ValueRay Target Price 398.3 -2.4%